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Congenital heart disease (CHD) is the most common birth defect in humans. It is a leading infant mortality factor worldwide,
caused by defective cardiac development. Mutations in transcription factors, signalling and structural molecules have been shown
to contribute to the genetic component of CHD. Recently, mutations in genes encoding myofibrillar proteins expressed in the
embryonic heart have also emerged as an important genetic causative factor of the disease, which implies that the contraction of
the early heart primordium contributes to its morphogenesis. This notion is supported by increasing evidence suggesting that not
only contraction but also formation, mechanosensing, and mechanotransduction of the cardiac myofibrillar proteins influence
heart development. In this paper, we summarize the genetic clues supporting this idea.
1. Introduction
The heart is the first organ to form in vertebrates during
embryogenesis, and cardiac contraction initiates shortly after
the cardiac tube is formed. The ever increasing needs of the
peripheral tissues of the growing embryo for nutrients and
oxygen are met gradually by the blood circulation induced
by early cardiac contraction. The heart primordium has to
perform its function for most of its own development, and
this unique feature has profound implications in the rela-
tionship between form and function during cardiogenesis:
factors that compromise early cardiac function result in
altered morphology, and heart malformation usually has an
important impact over the function of the organ. Defective
heart development results in congenital heart disease (CHD),
the commonest congenital defect in humans and a leading
cause of infant mortality worldwide. CHD is a complex dis-
ease, as multiple genetic and environmental factors have been
implicated in its pathogenesis. As in most complex diseases,
most cases are sporadic, although a relatively small fraction
of cases show familial segregation, following Mendelian pat-
terns of inheritance. The study and identification of the
genes causing the familial forms of the disorder can also give
important information about the genetic component of the
more common, complex variety.
Genetic linkage is a technique that identifies genes re-
sponsible for inherited traits solely based in their position on
chromosomes without prior knowledge of their product or
its function. More than two decades ago, by genetic linkage
analysis, a mutation of a gene encoding a myofibrillar protein
(β-cardiac myosin heavy chain, MYH7) was shown to
cause another cardiac disease, hypertrophic cardiomyopathy
(HCM) [1]. Since then, mutations in multiple genes encod-
ing myofibrillar proteins have been identified as responsible
for other cases of this disease and other types of cardiomy-
opathy: dilated cardiomyopathy (DCM), arrhythmogenic
right ventricular cardiomyopathy (ARVC), and restrictive
cardiomyopathy (RCM) (for a recent review, see Ghosh and
Haddad, 2011) [2].
The first genes shown to be responsible for familial cases
of CHD (NKX2-5 and GATA4) encode transcription factors.
Subsequently, mutations in genes that encode other types of
protein, like signalling and structural molecules, have been
described in families with Mendelian CHD, and common
variants have been identified as predisposing factors for non-
Mendelian CHD in large cohorts of sporadic cases (for a
review, see Wessels and Willems, 2010) [3].
Some relatively recent developments in the search for
the genetic origins of CHD were initiated by an unexpected
observation: a causative point mutation in chromosome 14
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was identified in a large family with an autosomal dominant
atrial septal defect (ASD), one of the most common forms of
CHD [4]. This mutation is located in a gene that encodes a
myofibrillar protein (α-cardiac myosin heavy chain, MYH6).
Subsequently, we and others have shown that mutations in
other genes that encode other myofibrillar proteins can cause
defective cardiac development [5–10]. Traditionally, com-
promised contractility of the cardiac muscle by the presence
of dominant-negative mutant myofibrillar proteins or their
haploinsuﬃciency (for nonsense mutations) was expected
to cause only functional phenotypes during postnatal life
which in turn induce a maladaptive response, as occurs
in the diﬀerent types of cardiomyopathy. The unexpected
observation that mutations in these genes can also aﬀect the
functionality of the heart during its early development and
thus induce cardiac malformation is supported by analysis of
spontaneous and induced mutations in model organisms.
In this paper, we discuss recent findings that indicate the
importance of the functionality of the myofibrils, specifically
their formation, contractility and mechanotransduction, in
several aspects of cardiogenesis.
2. Overview of Cardiac Development
Cardiac development is a complex process, by which an
initial primordium consists of a straight tube of cardiac
muscle (myocardium), lined by a single layer of endothelial
cells (endocardium) [11], bends to the right (looping) in
order to define the prospective chamber that receives blood
through the veins (primitive atrium) from the chamber
that expel blood to the arteries (primitive ventricle) [12].
The extracellular matrix that separates myocardium and
endocardium (cardiac jelly) expands to form the endo-
cardial cushions, located between the prospective atrium
and ventricle and between this and the prospective outflow
vessel [13]. The myocardium and endocardium forming the
wall of the future chambers expand (ballooning) [14] and
penetrate the interior of the chambers with ramified ridge-
like structures called trabeculae [15]. Both the primitive
atrium and ventricle are divided into right and left chambers
by atrial and ventricular septation, respectively, resulting
in the adult configuration of a right and left atria and a
right and left ventricle, and each ventricle is aligned with
its atrial counterpart [16]. Both the endocardial cushions
and the trabeculae contribute to both atrial and ventricular
septation. Additionally, the endocardial cushions condense
to form the valves between atria and ventricles and between
the ventricles and the prospective outflow vessels. Trabeculae
also form the papillary muscles that anchor the valves to the
inner surface of the ventricles [17].
3. Defective Myofibrillogenesis in the Heart
Causes Cardiac Malformation
In vivo studies in chicken and mouse have shown that
tropomodulin is an essential component of the myofibrils
required for its proper formation [18, 19]. This protein is
located in the membrane of the diﬀerentiating myocardial
cell, closely associated with spectrin [18]. Once tropomyosin
localizes within the thin filament, tropomodulin localizes in
the pointed end of the actin filament, where it is thought to
act as length stabilizer (Figure 1) [20].
Mice with targeted mutations of Tmod1 exhibit disrup-
tion of myofibrillogenesis, absence of cardiac contraction,
looping defects, trabeculation defects, thinning of the ven-
tricular wall, and impaired chamber formation [19, 21, 22].
4. Mutant Thick and Thin Filament
Proteins and Cardiogenesis: Lessons from
Animal Models
Analysis of spontaneous and experimental mutations in
animal models has highlighted the role of myofibrillar
proteins in cardiogenesis. In vertebrates, contraction of the
cardiac primordium through interaction between the thick
and thin filaments of the sarcomere occurs very early in
development, well before the circulation of blood is needed
to sustain the tissues of the embryo. It has been proposed
that this initial activity of the cardiac myofibril apparatus
functions as a stimulus for adequate heart development [23].
Deficiency of the genes encoding proteins of both the thick
and thin filaments of the sarcomere has been implicated in
cardiac malformation. For example, in the case of proteins of
the thin filament, mutations in the genes encoding cardiac
troponin t (tnnt2) and sarcomeric actin (cfk) in zebrafish
induce endocardial cushion and valve formation defects [24].
Targeted disruption of the cardiac troponin T gene (Tnnt2)
causes looping and endocardial cushion defects in mice [25].
In the case of genes encoding proteins of the thick filament,
mutation of the atrial myosin heavy chain gene (amhc)
results in deficient ventricular development [26]. Defective
atrial myosin heavy chain causes inadequate atrial septation
in chicken (MYH7) [27] and malformation of the valves
and trabeculae in the amphibian X. tropicalis (myh6) [28].
Abnormal cardiac chamber morphology, possibly due to
inadequate looping of enlarged and amorphous heart tubes,
was detected in mice with mutant atrial myosin regulatory
light chain (Myl7) gene [29].
5. Mutations of Myofibrillar Protein
Genes in CHD
The aforementioned finding by linkage that a mutation in
the α-myosin heavy chain gene (MYH6) causes a dominant
form of ASD [4] has been supported by reports of additional
mutations in the same gene in cases of ASD and other types
of CHD by us [6, 7] an others [10]. Recently, by array-
based sequence of 13 sarcomeric genes in 31 familial cases of
ASD, MYH6 was identified as the predominant sarcomeric
disease gene for ASD [10]. Additionally, mutations of the α-
cardiac actin gene (ACTC1) have been identified as causative
in other familial and sporadic cases of ASD [8]. Diﬀerent
mutations of the ACTC1 gene have been found in cases of
septal defects associated with ventricular noncompaction [9]
(expansion of the trabeculated component of the ventricular
wall at the expense of its compact layer). In cases of another
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Figure 1: Schematic representation of the structures of the myofibrils responsible of contraction, sensation, and transduction of mechanical
stimuli in the developing heart. Force is generated by the thick filaments formed by myosin heavy chain (amhc, MYH6, MYH7) associated
with myosin regulatory (Myl7) and essential light chains and their interaction with the thin filaments, formed by actin (ACTC1, cfk) and
troponin T (Tnnt2), TCAP and TMOD, amongst others. Titin spans a half of the sarcomere, from the Z-Disc (where it interacts with TCAP
and MLP) to the M-band. One of its intermediate segments, the N2A-region, acts as a mechanotransducer and binds CARP, DARP, and
ANKR2. The peripheral myofibrils of the cardiomyocytes are linked to integrins embedded in the cell membrane (sarcolemma) by means of
the focal adhesion complexes of the costameres, formed by FAK ERK1 and ERK2, amongst others. In response to mechanical stimulation,
proteins bound to titin (CARP, DARP, and ANKR2), proteins of the Z-Disc (MLP, PKCε), as well as FAK, ERK1, and ERK2, located to the
focal adhesion complexes, translocate to the nucleus, where they interact with cardiac transcription factors to modify gene expression.
type of CHD (Ebstein’s anomaly) associated with ventricular
noncompaction, mutations of the β-myosin heavy chain
gene (MYH7) have been identified [5]. Other mutations
of MYH6, ACTC1, and MYH7 also cause hypertrophic and
dilated cardiomyopathy [2, 30–32].
6. Mechanotransduction of Myofibrils and
Heart Development
Besides their function in contraction, specific myofibrillar
and associated proteins can also act as sensors and trans-
ducers of the strains imposed by their own activity and
the resulting fluid dynamics. The function of some of these
mechanosensors and transducers could be relevant for car-
diac development.
Titin, the largest myofibrillar protein, spans half of the
sarcomere as it links its outer limit (the Z-band) with its
centre (the M-band). This protein is composed of a series
of springs of variable resistance that provide elasticity to the
myofibrils and also contains segments that act as mecha-
nosensors [33, 34]. The Ig-domains 180 and 181 in the N2A-
region of titin interact with three proteins of the muscle
ankyrin-repeat family, CARP (also known as ANKRD1 and a
known target of NKX2.5 [35] and other cardiac transcription
factors [36]), DARP, and Ankrd2 [37, 38]. When stretch is
applied to cardiomyocytes, CARP translocates to the nucleus,
where it interacts with transcription factors to modify gene
expression [39]. A mutation on the ANKRD1 gene that
enhances the stability and potentiates the transcriptional
repression of the cardiac specific ANF promoter was de-
scribed in a patient with total anomalous pulmonary venous
return (TAPVR, another type of CHD, where the pulmonary
vein empties in a vessel or cardiac chamber diﬀerent from the
right atria). A chromosomal translocation with a breakpoint
near the ANKRD1 gene was discovered in another patient
with the same abnormality [40].
Mechanical stimuli are first transmitted to themembrane
of the cardiomyocytes (sarcolemma) through the extracel-
lular matrix. Myofibrils are bound to the membrane of
cardiomyocytes via specialized focal adhesion complexes
concentrated in the costameres. These structures link the
sarcolemma to the Z-bands of the sarcomeres that form the
peripheral myofibrils [41]. The mechanotransduction of the
focal adhesion complexes at the costameres includes phos-
phorylation of focal adhesion kinase (FAK), extracellular
signal-regulated kinases 1 and 2 (ERK1 and ERK2), and pax-
illin (PXN) (Figure 1) [42].
It has been shown that the focal adhesion complexes at
the costameres can react diﬀerentially according to the rate
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and direction of the strain applied to the cell. Prolonged
static strain over cardiomyocytes causes FAK to translocate
from the focal adhesion complex to the nucleus [42].
Transverse strain (perpendicular to the sarcomere) increases
the phosphorylation of FAK, ERK1, and ERK2 in comparison
with nonstrained cells, whereas longitudinal strain (parallel
to the sarcomere) induces the phosphorylation of ERK1 and
ERK2 but does not increase phosphorylation of FAK [42].
It has been proposed that transverse strain extends the FAK
molecule, promoting its activation by phosphorylation [43].
Deficiency of FAK in produces a general defect of meso-
derm development in mice [44] and, specifically in the devel-
oping heart, results in compromised migration of neural
crest cells to the cardiac outflow tract, which in turn induces
malformation of conotruncus [45]. However, myocardium-
specific ablation of the FAK gene induces ventricular septal
defects (VSDs) and deficient cardiomyocyte proliferation in
mice, which suggests that the role of FAK as a mechanotrans-
ducer is also important for cardiogenesis and specifically for
ventricular septation [46]. Knockdown of FAK transcripts by
antisense morpholino induced looping defects in X. laevis
[47]. Upon activation by phosphorylation, ERK1 and 2
translocate to the nucleus [48] and are known to partici-
pate in several processes important for heart development,
including FGF, BMP, and VEGF signalling [49]. Moreover,
a 1Mb microdeletion in chromosome 22q11.2 spanning the
ERK2 gene has been described in patients with VSD and PTA
[50]. Ablation of the PXN gene in mice results in abnormal
heart structure [51]. These data suggest a possible mecha-
nism by which cardiac contraction and the resulting circu-
lation of blood in early development can, in turn, promote
heart development by inducing cardiomyocyte proliferation.
In contrast, animal models of mutations of genes encod-
ing other proteins known to act as mechanosensors in the
cardiac Z-band and the costameres do not display cardiac
malformation. In response to variations in mechanical stress,
muscle LIM protein (MLP) translocates to the nucleus [52],
where it has been proposed to bind cardiac transcription
factors like GATA4 [53]. Also, it has been hypothesised
that MLP forms a complex with telethonin (TCAP) and
the N-terminal Z1 and Z2 domains of titin that acts as
a stretch sensor in cardiomyocytes [54]. Protein kinase C
epsilon (PKCε) is necessary and suﬃcient to induce FAK
autophosphorylation [55], and it is known to localize to
the Z-band in cardiomyocytes [56] and to translocate to
the nucleus in response to pressure overload [57], where
it has been suggested to regulate the transcription of α-
skeletal actin [58]. Humans or mice harbouring mutations
of the genes encoding MLP [54, 59], TCAP [60, 61], or PKCε
[62] do not show cardiac malformation. Further research is
required to establish why defective specific mechanosensing
pathways of the myofibrils and associated structures have a
deleterious eﬀect in cardiogenesis and others do not.
7. Conclusions
Mutations in many genes that encode proteins involved
in the formation, contraction as well as force sensing and
transduction of the myofibrils produce phenotypes that
include impaired cardiac development in animal models and
humans. It is being increasingly recognized that the early
activity of the embryonic heart has a significant impact in the
morphogenesis of the organ. The sensing and transduction
of the forces it generates modify the gene expression of the
early myocardium, which elicits remodelling, proliferation,
and possibly apoptosis. Thus, we suggest that gene candidate
approaches designed to discover new genetic determinants
of Mendelian CHD or common variants predisposing to the
nonfamilial CHD should consider genes involved in these
signalling pathways.
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